NASDAQ Biotechnology Index
From Wikipedia, the free encyclopedia
The NASDAQ Biotechnology Index includes securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria.
As of 2005-03-26 the companies included in the index are:
| Name | Symbol | Headquarters | Description |
|---|---|---|---|
| Abgenix | NASDAQ: ABGX | Fremont, California | |
| Accelrys | NASDAQ: ACCL | San Diego, California | |
| Adolor Corporation | NASDAQ: ADLR | Exton, Pennsylvania | |
| Affymetrix | NASDAQ: AFFX | Santa Clara, California | produces DNA microarrays |
| Albany Molecular Research | NASDAQ: AMRI | ||
| Alexion Pharmaceuticals | NASDAQ: ALXN | ||
| Alkermes, Inc. | NASDAQ: ALKS | Boston, Massachusetts | |
| Alnylam Pharmaceuticals | NASDAQ: ALNY | Cambridge, Massachussetts | |
| American Pharmaceutical Partners | NASDAQ: APPX | ||
| Amgen | NASDAQ: AMGN | Thousand Oaks, California | |
| Amylin Pharmaceuticals | NASDAQ: AMLN | ||
| Anadys Pharmaceuticals | NASDAQ: ANDS | ||
| Angiotech Pharmaceuticals | NASDAQ: ANPI | Vancouver, British Columbia | |
| Antigenics | NASDAQ: AGEN | New York, New York | Prophylactic/Therapeutic Vaccines and Chemotherapeutics |
| Arena Pharmaceuticals | NASDAQ: ARNA | ||
| ARIAD Pharmaceuticals | NASDAQ: ARIA | ||
| ArQule | NASDAQ: ARQL | Woburn, Massachusetts | |
| Array BioPharma | NASDAQ: ARRY | ||
| AtheroGenics | NASDAQ: AGIX | ||
| Axcan Pharma | NASDAQ: AXCA | Mont-Saint-Hilaire, Quebec | |
| Barrier Therapeutics | NASDAQ: BTRX | ||
| BioCryst Pharmaceuticals | NASDAQ: BCRX | Birmingham, Alabama | |
| Bioenvision | NASDAQ: BIVN | New York, New York | |
| Biogen Idec | NASDAQ: BIIB | Cambridge, Massachusetts | |
| BioMarin Pharmaceutical | NASDAQ: BMRN | Novato, California | |
| Biosite | NASDAQ: BSTE | ||
| BioVeris Corporation | NASDAQ: BIOV | ||
| Caliper Life Sciences | NASDAQ: CALP | ||
| Cardiome Pharma Corporation | NASDAQ: CRME | ||
| Celgene Corporation | NASDAQ: CELG | Summit, New Jersey | |
| Cell Genesys | NASDAQ: CEGE | San Francisco, California | Various cancer therapies |
| Cell Therapeutics | NASDAQ: CTIC | Seattle, Washington | |
| Cephalon | NASDAQ: CEPH | ||
| Chiron Corporation | NASDAQ: CHIR | Emeryville, California | |
| Connetics Corporation | NASDAQ: CNCT | ||
| CoTherix | NASDAQ: CTRX | South San Francisco, California | |
| Crucell NV | NASDAQ: CRXL | ||
| Cubist Pharmaceuticals | NASDAQ: CBST | Lexington, Massachusetts | |
| CuraGen Corporation | NASDAQ: CRGN | ||
| Curis | NASDAQ: CRIS | Cambridge, Massachusetts | |
| CV Therapeutics | NASDAQ: CVTX | ||
| Cypress Bioscience | NASDAQ: CYPB | ||
| Cytokinetics Incorporated | NASDAQ: CYTK | ||
| deCODE genetics | NASDAQ: DCGN | Reykjavík, Iceland | |
| Dendreon Corporation | NASDAQ: DNDN | ||
| DepoMed | NASDAQ: DEPO | ||
| Digene Corporation | NASDAQ: DIGE | ||
| Discovery Laboratories | NASDAQ: DSCO | ||
| Diversa Corporation | NASDAQ: DVSA | ||
| DOV Pharmaceutical | NASDAQ: DOVP | ||
| Draxis Health | NASDAQ: DRAX | ||
| Durect Corporation | NASDAQ: DRRX | ||
| Dyax Corp. | NASDAQ: DYAX | ||
| Encysive Pharmaceuticals | NASDAQ: ENCY | ||
| Endo Pharmaceuticals Holdings | NASDAQ: ENDP | ||
| Enzon Pharmaceuticals | NASDAQ: ENZN | ||
| EPIX Pharmaceuticals | NASDAQ: EPIX | ||
| Exelixis | NASDAQ: EXEL | ||
| First Horizon Pharmaceutical Corporation | NASDAQ: FHRX | ||
| Flamel Technologies S.A. | NASDAQ: FLML | ||
| Gen-Probe Incorporated | NASDAQ: GPRO | ||
| Gene Logic | NASDAQ: GLGC | ||
| Genitope Corporation | NASDAQ: GTOP | ||
| Genta Incorporated | NASDAQ: GNTA | ||
| Genzyme General | NASDAQ: GENZ | Cambridge, Massachusetts | |
| Geron Corporation | NASDAQ: GERN | Menlo Park, California | |
| Gilead Sciences | NASDAQ: GILD | Foster City, California | |
| Harvard Bioscience | NASDAQ: HBIO | ||
| Hi-Tech Pharmacal | NASDAQ: HITK | ||
| Hollis-Eden Pharmaceuticals | NASDAQ: HEPH | ||
| Human Genome Sciences | NASDAQ: HGSI | Rockville, Maryland | |
| ICOS Corporation | NASDAQ: ICOS | ||
| Idenix Pharmaceuticals | NASDAQ: IDIX | ||
| Illumina | NASDAQ: ILMN | ||
| ImClone Systems Incorporated | NASDAQ: IMCL | New York, New York | |
| ImmunoGen | NASDAQ: IMGN | ||
| Immunomedics | NASDAQ: IMMU | ||
| Incyte Corporation | NASDAQ: INCY | ||
| Indevus Pharmaceuticals | NASDAQ: IDEV | ||
| Inspire Pharmaceuticals | NASDAQ: ISPH | ||
| InterMune | NASDAQ: ITMN | ||
| Introgen Therapeutics | NASDAQ: INGN | ||
| Invitrogen Corporation | NASDAQ: IVGN | ||
| Isis Pharmaceuticals | NASDAQ: ISIS | ||
| ISTA Pharmaceuticals | NASDAQ: ISTA | ||
| Keryx Biopharmaceuticals | NASDAQ: KERX | ||
| Kos Pharmaceuticals | NASDAQ: KOSP | ||
| Kosan Biosciences Incorporated | NASDAQ: KOSN | ||
| Lexicon Genetics Incorporated | NASDAQ: LEXG | The Woodlands, Texas | |
| LifeCell Corporation | NASDAQ: LIFC | ||
| Luminex Corporation | NASDAQ: LMNX | ||
| MannKind Corporation | NASDAQ: MNKD | ||
| Martek Biosciences Corporation | NASDAQ: MATK | ||
| Medarex | NASDAQ: MEDX | ||
| Medicines Company | NASDAQ: MDCO | ||
| MedImmune | NASDAQ: MEDI | Gaithersburg, Maryland | |
| MGI PHARMA | NASDAQ: MOGN | ||
| Millennium Pharmaceuticals | NASDAQ: MLNM | Cambridge, Massachusetts | |
| Momenta Pharmaceuticals | NASDAQ: MNTA | ||
| Monogram Biosciences | NASDAQ: MGRM | ||
| Myogen | NASDAQ: MYOG | ||
| Myriad Genetics | NASDAQ: MYGN | ||
| Nabi Biopharmaceuticals | NASDAQ: NABI | ||
| Nastech Pharmaceutical Company | NASDAQ: NSTK | ||
| Nektar Therapeutics | NASDAQ: NKTR | ||
| NeoPharm | NASDAQ: NEOL | ||
| Neurochem | NASDAQ: NRMX | ||
| Neurocrine Biosciences | NASDAQ: NBIX | ||
| NitroMed | NASDAQ: NTMD | ||
| Northfield Laboratories | NASDAQ: NFLD | ||
| Noven Pharmaceuticals | NASDAQ: NOVN | ||
| NPS Pharmaceuticals | NASDAQ: NPSP | ||
| Nuvelo | NASDAQ: NUVO | ||
| ONYX Pharmaceuticals | NASDAQ: ONXX | ||
| Orchid Cellmark | NASDAQ: ORCH | ||
| Oscient Pharmaceuticals Corporation | NASDAQ: OSCI | ||
| OSI Pharmaceuticals | NASDAQ: OSIP | New York, New York | |
| Pain Therapeutics | NASDAQ: PTIE | ||
| Panacos Pharmaceuticals | NASDAQ: PANC | ||
| PAREXEL International Corporation | NASDAQ: PRXL | ||
| PDL BioPharma | NASDAQ: PDLI | ||
| Penwest Pharmaceuticals | NASDAQ: PPCO | ||
| Perrigo Company | NASDAQ: PRGO | ||
| Pharmacyclics | NASDAQ: PCYC | ||
| Pharmion Corporation | NASDAQ: PHRM | Boulder, Colorado | |
| Pozen | NASDAQ: POZN | ||
| Progenics Pharmaceuticals | NASDAQ: PGNX | ||
| Qiagen N.V. | NASDAQ: QGEN | ||
| QLT | NASDAQ: QLTI | ||
| Regeneron Pharmaceuticals | NASDAQ: REGN | Tarrytown, New York | |
| Renovis | NASDAQ: RNVS | Cambridge, Massachusetts | |
| Rigel Pharmaceuticals | NASDAQ: RIGL | ||
| Salix Pharmaceuticals | NASDAQ: SLXP | ||
| Santarus | NASDAQ: SNTS | ||
| Savient Pharmaceuticals | NASDAQ: SVNT | ||
| SciClone Pharmaceuticals | NASDAQ: SCLN | ||
| Seattle Genetics | NASDAQ: SGEN | ||
| Sepracor | NASDAQ: SEPR | Marlborough, Massachusetts | |
| Serologicals Corporation | NASDAQ: SERO | ||
| SFBC International | NASDAQ: SFCC | ||
| Shire | NASDAQ: SHPGY | Basingstoke, Hampshire | |
| Sirna Therapeutics | NASDAQ: RNAI | ||
| StemCells | NASDAQ: STEM | ||
| SuperGen | NASDAQ: SUPG | Dublin, California | |
| Tanox | NASDAQ: TNOX | ||
| Taro Pharmaceutical Industries | NASDAQ: TARO | ||
| Techne Corporation | NASDAQ: TECH | ||
| Telik | NASDAQ: TELK | ||
| Tercica | NASDAQ: TRCA | ||
| Teva Pharmaceutical Industries Limited | NASDAQ: TEVA | ||
| Third Wave Technologies | NASDAQ: TWTI | ||
| Trimeris | NASDAQ: TRMS | ||
| United Therapeutics Corporation | NASDAQ: UTHR | ||
| Vasogen | NASDAQ: VSGN | ||
| Vertex Pharmaceuticals Incorporated | NASDAQ: VRTX | ||
| ViaCell | NASDAQ: VIAC | ||
| ViroPharma Incorporated | NASDAQ: VPHM | Exton, Pennsylvania | |
| Vivus | NASDAQ: VVUS | ||
| XOMA | NASDAQ: XOMA | ||
| ZymoGenetics | NASDAQ: ZGEN | Seattle, Washington |
